Get started
Author

Jennifer Yesil

Observed names: J Yesil, Yesil J
OpenAlex ID: A5000508881
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
2022 · Josh N. Vo, Yi-Mi Wu, et al. · Nature Communications · 91
PDF
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma
2017 · A Laganà, D Perumal, et al. · Leukemia · 68
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020 · Mattia D'Agostino, Gian Maria Zaccaria, et al. · Clinical Cancer Research · 64
PDF
A Comparison of Clinical FISH and Sequencing Based FISH Estimates in Multiple Myeloma: An Mmrf Commpass Analysis
2016 · Chase Miller, Jennifer Yesil, et al. · Blood · 22
Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study
2021 · Sheri Skerget, Daniel Penaherrera, et al. · medRxiv · 19
Minimal Residual Disease Evaluation By Multiparameter Flow Cytometry and Next Generation Sequencing in the Forte Trial for Newly Diagnosed Multiple Myeloma Patients
2019 · Stefania Oliva, Elisa Genuardi, et al. · Blood · 19
Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study
2016 · Jonathan J Keats, Gil Speyer, et al. · Blood · 16
A Next Generation Liquid Biopsy Approach for Multiple Myeloma
2020 · Daniel Auclair, Mark Bustoros, MD, et al. · Blood · 8
Increased HLA-E Expression Correlates with Early Relapse in Multiple Myeloma
2018 · Alessandro Lagana, Dan Fu Ruan, et al. · Blood · 8
FGFR3 Mutations Are an Adverse Prognostic Factor in Patients with t(4;14)(p16;q32) Multiple Myeloma: An Mmrf Commpass Analysis
2017 · Brooks A. Benard, Austin Christofferson, et al. · Blood · 8
Patient Treatment Preferences for Relapsed/Refractory Multiple Myeloma: Are Patients Willing to Trade Off Efficacy for Tolerability?
2018 · Daniel Auclair, Carol Mansfield, et al. · Blood · 7
Comprehensive Identification of Fusion Transcripts in Multiple Myeloma: An Mmrf Commpass Analysis
2017 · Sara Nasser, Austin Christofferson, et al. · Blood · 6
Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project
2017 · Alessandro Laganà, David T. Melnekoff, et al. · Blood · 4
The Mydrug Platform Trial: Efficacy and Safety of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Patients with Functionally High-Risk Multiple Myeloma
2022 · Shaji K Kumar, Craig C Hofmeister, et al. · Blood · 3
Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma Patients
2019 · J Christine Ye, Liying Chen, et al. · Blood · 3
Network Modeling Reveals CDC42BPA and CLEC11A As Novel Driver Genes of t(4; 14) Multiple Myeloma
2016 · Deepak Perumal, Alessandro Lagana', et al. · Blood · 3
Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis
2019 · Austin Christofferson, Sheri Skerget, et al. · Blood · 2
Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype
2018 · Sheri Skerget, Daniel Penaherrera, et al. · Blood · 2
Multiple Myeloma Drivers of High Risk and Response to Stem Cell Transplantation Identified By Causal Machine Learning: Out-of-Cohort and Experimental Validation
2017 · Leon Furchtgott, Arnold Bolomsky, et al. · Blood · 2
A Molecular Analysis of Cereblon-Related Immunomodulatory Drug Resistance in Commpass Multiple Myeloma Patients
2017 · Sheri Skerget, Brooks A. Benard, et al. · Blood · 2
Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach
2017 · Daniel Auclair, Carol Mansfield, et al. · Blood · 2
Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature
2016 · Alessandro Lagana, Deepak Perumal, et al. · Blood · 2
Interim Analysis of Mmrf Curecloud Research Initiative Identifies High Prevalence and Patterns of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations in a Real World Myeloma Cohort
2021 · Reyka G Jayasinghe, Annette S. Kim, et al. · Blood · 1
Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)
2020 · Christopher T Su, Liying Chen, et al. · Blood · 1
Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study
2019 · Sheri Skerget, Austin Christofferson, et al. · Blood · 1
Works count: 42
Citation count: 367
H-index: 8
I10-index: 7
Year
Topic
Type